EVIALIS LAUNCHES NEW ANIMAL NUTRITION ADDITIVES AT EUROTIER NEXT MONTH (Y100)
EVIALIS LAUNCHES NEOVIA, RANGE OF ANIMAL NUTRITION ADDITIVES, AT EUROTIER EXHIBITION IN HANOVER, GERMANY, NEXT MONTH
[USPRwire, Thu Oct 30 2008] Continuing its innovative approach towards animal feed additives, the Evialis Group is about to launch the Neovia range comprising five high-performance products: T5X stimulates natural detoxification, B-Safe boosts the gastrointestinal defense mechanisms, Stimune promotes the transfer of immunity in piglets, Oilis strengthens the intestinal walls and helps to control the risk of coccidiosis and Cap’Acid safeguards digestion via controlled diffusion of these protected acids. The specific technical features of these products will be unveiled during a press conference scheduled for 3 p.m. on November 12, 2008, at the Eurotier Exhibition in Hanover, Germany.
Three of the Neovia additives, T5X, B-Safe, and Stimune, are previewed in this release. The remaining two will be detailed at the press conference.
T5X acts at four complementary stages to help the body combat mycotoxins. It binds mycotoxins by virtue of specific components, stimulates natural detoxification in the liver, prevents oxidative stress in cells, and boosts the immune response. T5X offers an all-round solution for combating a wide range of mycotoxins (not only polar mycotoxins such as aflatoxins, but also less polar groups such as ZEA and DON, etc.).
Based on an entirely innovative and patented mode of action, B-Safe helps to maintain the digestive balance in monogastric animals. Comprising plant extracts and specific clays, it limits the development of pathogenic gastrointestinal flora whilst protecting the intestinal mucosa at the same time. B-Safe enhances the zootechnical performance results of animals and boosts breeding profitability, especially under difficult hygiene conditions.
Stimune guarantees the transfer of passive immunity and induces active immunity in newborn animals to increase the pre-weaning survival rate. Tests carried out by Evialis have highlighted a rise in immunoglobulin levels in the colostrum, milk, and in piglets' blood. Thanks to greater immunity, the animals are more resistant, resulting in a 45% increase in survival rate in parturition accommodation (based on the mean result of tests carried out) and up to 0.7 piglets saved per litter.
The Neovia supplements range offers original concepts with proven results through natural products that satisfy manufacturers’ requirements. Neovia has boosted powerful research and development resources in order to target individual market needs more effectively. A 100-strong team of international researchers at five locations have been set up across the globe in France, Brazil, Vietnam, Indonesia, and India. This strategic choice provides unparalleled reactivity. Furthermore, Neovia research benefits from close collaboration with universities and independent R&D centres.
In vivo models have been implemented to test the reliability of each innovation under conditions very similar to those encountered in practice: mycotoxin challenge, coccidiosis and enterocolitis models, etc. Granted ISO 9001 (version 2000) and GMP (Good Manufacturing Practice) certification, Neovia additives are produced in factories at the cutting edge of technology.
The Evialis Group will exhibit at the Eurotier Exhibition in Hanover, Germany, at booth D20 in Hall 14. The press conference for the launch of the Neovia products will be Wednesday, November 12, 2008, at 3 p.m. in the Leipzig Room in the Convention Center.
For more information, please contact:
NEOVIA, a brand of EVIALIS
Pierre Defalque/ Danièle Marzin
Export Director / Additives Market Manager
56009 Vannes Cedex
Tel.: +33 (0)2 97 48 53 83
Fax: +33 (0)2 97 48 53 85
FRENCH TECHNOLOGY PRESS OFFICE
205 North Michigan Avenue, Suite 3740
Chicago, IL 60601
Fax: (312) 327-5261